Building Institutional Capacity to Improve HIV-TB Care and Treatment Service Quality in India under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 154002CONT16

Opportunity Information: Apply for CDC RFA GH15 154002CONT16

The grant opportunity titled "Building Institutional Capacity to Improve HIV-TB Care and Treatment Service Quality in India under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a Centers for Disease Control and Prevention (CDC) funding action designed to continue support for an existing, already-funded program focused on strengthening HIV and tuberculosis (TB) service delivery in India. The core aim is institutional capacity building, meaning it emphasizes improving the systems, skills, and organizational infrastructure that underpin high-quality HIV-TB care and treatment rather than launching a brand-new initiative. The opportunity is positioned within PEPFAR, the United States government's global HIV response platform, which commonly prioritizes improvements in clinical quality, program management, monitoring and evaluation, and sustainability of HIV-related services, especially where HIV-TB co-infection is a major contributor to illness and death.

This specific posting is categorized as continuation funding and is not broadly open to new applicants. The description states that the award is a continuation of funds intended only for grantees previously awarded under the earlier related funding announcement, identified as CDC-RFA-GH15-1540. In practice, this means the CDC is extending or renewing a cooperative agreement with an existing recipient (notably referenced as "SHARE India" in the description), rather than running a competitive process to select new implementers. The funding instrument is a cooperative agreement, which typically indicates substantial CDC involvement in the work, such as technical collaboration, shared planning, guidance on implementation approaches, and alignment with CDC and PEPFAR reporting and performance standards.

From an administrative standpoint, the opportunity is recorded under Funding Opportunity Number "CDC RFA GH15 154002CONT16" and falls under the activity category of Health, with CFDA number 93.067. The agency is the Centers for Disease Control and Prevention. The expected number of awards is one, reinforcing that it is designed to continue a single ongoing project rather than fund multiple new projects. The original closing date listed is October 19, 2015, with a creation date of September 21, 2015. The award ceiling is listed as 0, which often appears in continuation notices when a specific maximum amount is not publicly specified in the synopsis or is managed through internal budgeting tied to the existing award and year-to-year continuation decisions.

Substantively, the program focus on HIV-TB care and treatment service quality in India reflects the public health reality that TB is a leading cause of death among people living with HIV, and improving integrated HIV-TB services can have an outsized impact on patient outcomes. Capacity-building efforts under this kind of award commonly include strengthening clinical protocols and quality improvement systems; improving linkages between HIV testing and TB screening, diagnosis, and treatment; supporting antiretroviral therapy (ART) and TB treatment adherence and retention in care; enhancing infection control practices in healthcare settings; building workforce competencies through training and mentorship; and improving data systems so facilities and programs can track outcomes, identify gaps, and respond quickly. The emphasis on "institutional" capacity suggests a focus on making these improvements durable by embedding them in organizational processes, supervision structures, and routine performance management rather than relying on short-term project inputs.

Overall, this is a targeted continuation action by CDC under PEPFAR to sustain and deepen ongoing work in India aimed at improving the quality and effectiveness of HIV-TB care and treatment services, with eligibility effectively limited to the previously funded grantee under the earlier CDC-RFA-GH15-1540 announcement and with CDC maintaining an active partnership role through the cooperative agreement structure.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Building Institutional Capacity to Improve HIV-TB Care and Treatment Service Quality in India under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-09-21.
• Applicants must submit their applications by 2015-10-19. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others.

Apply for CDC RFA GH15 154002CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: